EWTX Earnings Date: Nov 5, 2026 (Estimated) — Edgewise Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is EWTX's next earnings date?
Edgewise Therapeutics, Inc. (EWTX) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.53 on revenue of $119.2M.
How did EWTX do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Edgewise Therapeutics, Inc. posted EPS of -$0.53 versus the -$0.47 estimate, a miss of 10.4%. Revenue was $0. The stock's 1-day post-earnings move was -1.3%.
How much does EWTX stock move after earnings?
EWTX beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.7% (up or down) in the day after earnings.
About Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.47 | -0.53 | -10.42% | $0 | ❌ Miss | -1.27% | -3.18% | -6.76% |
| 2026-05-07 | Q1 2026 | -0.49 | -0.46 | +6.12% | $0 | ✅ Beat | -3.81% | -8.73% | -3.78% |
| 2026-02-26 | Q4 2025 | -0.44 | -0.47 | -6.82% | $0 | ❌ Miss | -1.53% | -4.12% | +5.08% |
| 2025-11-06 | Q3 2025 | -0.40 | -0.39 | +2.50% | $0 | ✅ Beat | -1.61% | +21.88% | +35.81% |
| 2025-03-03 | Q4 2024 | -0.40 | -0.42 | -5.00% | $0 | ❌ Miss | -2.45% | +7.03% | -15.93% |
| 2024-11-07 | Q3 2024 | -0.37 | -0.36 | +2.70% | $0 | ✅ Beat | -3.25% | -9.18% | -11.00% |
| 2024-02-22 | Q4 2023 | -0.43 | -0.47 | -9.30% | $0 | ❌ Miss | -0.74% | -4.86% | -3.49% |
| 2023-11-09 | Q3 2023 | -0.40 | -0.41 | -2.50% | $0 | ❌ Miss | -7.29% | +6.32% | +12.97% |
Showing last 8 quarters.